Leadership Team Our leadership team is comprised of seasoned executives with track records translating scientific discoveries into successful global drug approvals. Nima FarzanChief Executive OfficerRead more →Neil Singla, M.D.Chief Medical OfficerRead more →Neha KrishnamohanChief Financial Officer and Chief Business OfficerRead more →Julia ChapmanSenior Vice President, OperationsRead more →Polina German, Pharm.D.Senior Vice President, Clinical Pharmacology and TranslationalRead more →Bryan Moyer, Ph.D.Senior Vice President, DiscoveryRead more →Becky BaggettVice President, Clinical OperationsRead more →Holly Carlisle, Ph.D.Vice President, Translational ScienceRead more →Anil Chhettry, Ph.D.Vice President, Chemistry, Manufacturing and ControlsRead more →Caroline DoughertyVice President, Corporate DevelopmentRead more →Mike Kaufman, Ph.D.Vice President, ChemistryRead more →Sabrina NiederVice President, Corporate ControllerRead more →Sarah PophamVice President, RegulatoryRead more →Ben VaughnVice President, BiostatisticsRead more →Cynthia VoongVice President, Clinical OperationsRead more →Board of DirectorsTimothy P. WalbertChair, Board of DirectorsRead more →Nima FarzanChief Executive Officer, Latigo BiotherapeuticsRead more →Deborah Palestrant, Ph.D., M.B.A.Partner, 5AM Ventures and Executive Chair, 4:59 InitiativeRead more →Kevin RaidySenior Managing Director, Blue Owl Capital & Audit Committee ChairRead more →Beth Seidenberg, M.D.Founding Managing Director, Westlake Village BioPartnersRead more →Jim Tananbaum, M.D.Founder and Chief Executive Officer, Foresite CapitalRead more →
